Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
Recruiting · NCT06254768 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, Los Angeles
View the official record on ClinicalTrials.gov →Interventions studied
Continuous glucose monitor
What this trial is about
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
Who can take part
Age range
10 Years to 21 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 10-21 years BMI \>95th percentile
Exclusion criteria
- Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
- Intellectual disability
- Previous or planned bariatric surgery
- Hemoglobin A1c \>6.5 %
- Current use of medication that impacts weight
Where it is running
1 location listed across 1 US state.
- Pediatric Endocrinology Division, University of California - Los Angeles, California, United States